Two weeks ago, on May 31st, we looked at SOLY‘s rather bizarre, undocumented, “clinical trial” for their RAP device.
In an obvious attempt to cover their tracks, on June 10th the company hastily registered a trial into the government’s Clinicaltrials.gov database.
Naturally, this being a Reg scAm bioturd, the “trial” is a complete joke. Just 5 patients, no control arm, and no blinding.
And just as naturally, for a stock promotion, two days later, on June 12th, SOLY put out a press release announcing that the results from this PoC Cellulite Trial would be presented in July!
SOLY’s Walter Klemp and his krim klown krew sure are busy beavers. From listing the study to announcing the upcoming announcement of results in just 2 days. Maybe they can give Enron Linda a hand with the NWBO trial.
Odd that Wally can promise 26 week trial data in mid July for a trial that didn’t exist, according to government records, before the 10th of June.
Of course all of this is just stock promotion window dressing. 510(k) devices are not approved for indications, they are “cleared”, and no trials are actually needed for 510(k) devices. Which is good, because what SOLY calls “trials” are just content creation exercises for shameless stock promotion.